Liquidia (LQDA) Gross Profit Growth (3y) (2023 - 2026)
Liquidia (LQDA) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Liquidia | 6.39 Bn | 6.10 Bn | 160.92 Mn | 239.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 239.43% |
| Mar 31, 2026 | 216.56% |
| Dec 31, 2025 | 165.05% |
| Sep 30, 2025 | 177.90% |
| Jun 30, 2025 | 33.28% |
| Mar 31, 2025 | -16.95% |
| Dec 31, 2024 | -14.37% |
| Sep 30, 2024 | 7.99% |
| Jun 30, 2024 | -6.64% |
| Mar 31, 2024 | -14.29% |
| Dec 31, 2023 | 91.74% |